Cell Cycle-Dependent Adaptor Complex for Clpxp-Mediated Proteolysis Directly Integrates Phosphorylation and Second Messenger Signals

Total Page:16

File Type:pdf, Size:1020Kb

Cell Cycle-Dependent Adaptor Complex for Clpxp-Mediated Proteolysis Directly Integrates Phosphorylation and Second Messenger Signals Cell cycle-dependent adaptor complex for ClpXP-mediated proteolysis directly integrates phosphorylation and second messenger signals Stephen C. Smitha, Kamal K. Joshib,1, Justin J. Zika,1, Katherine Trinha, Aron Kamajayaa, Peter Chienb,2, and Kathleen R. Ryana,2 aDepartment of Plant and Microbial Biology, University of California, Berkeley, CA 94720; and bProgram in Molecular and Cellular Biology, Department of Biochemistry and Molecular Biology, University of Massachusetts, Amherst, MA 01003 Edited by Sue Wickner, National Cancer Institute, National Institutes of Health, Bethesda, MD, and approved August 8, 2014 (received for review April 29, 2014) The cell-division cycle of Caulobacter crescentus depends on peri- Although ClpX alone recognizes some substrates, the degrada- odic activation and deactivation of the essential response regula- tion of other substrates requires or is enhanced by adaptor proteins tor CtrA. Although CtrA is critical for transcription during some (9). For example, the Escherichia coli protein SspB is an adaptor parts of the cell cycle, its activity must be eliminated before chro- for the degradation of substrates with a C-terminal ssrA peptide mosome replication because CtrA also blocks the initiation of DNA (10), which arise during failed translation events (11). SspB binds replication. CtrA activity is down-regulated both by dephosphory- to ClpX and to the ssrA peptide, increasing the local effective lation and by proteolysis, mediated by the ubiquitous ATP-dependent substrate concentration through tethering (12, 13). Adaptors protease ClpXP. Here we demonstrate that proteins needed for themselves can be tightly regulated; for example, the response rapid CtrA proteolysis in vivo form a phosphorylation-dependent regulator RssB acts as an adaptor for the rapid ClpXP-mediated and cyclic diguanylate (cdG)-dependent adaptor complex that proteolysis of the stationary phase sigma factor RpoS during ex- accelerates CtrA degradation in vitro by ClpXP. The adaptor com- ponential growth in E. coli (14). In stationary phase or in response plex includes CpdR, a single-domain response regulator; PopA, to specific stresses, up-regulation of antiadaptor proteins that block MICROBIOLOGY a cdG-binding protein; and RcdA, a protein whose activity cannot RssB from binding RpoS drives a surge in RpoS levels (15, 16). be predicted. When CpdR is unphosphorylated and when PopA is In the Caulobacter cell cycle, CtrA proteolysis is spatially and bound to cdG, they work together with RcdA in an all-or-none temporally restricted such that it occurs only during the G1–S K manner to reduce the m of CtrA proteolysis 10-fold. We further transition, either during the development of a motile swarmer identified a set of amino acids in the receiver domain of CtrA that cell into a sessile stalked cell, or in the stalked compartment of modulate its adaptor-mediated degradation in vitro and in vivo. the late predivisional cell (Fig. 1; ref. 17). In addition to ClpX Complex formation between PopA and CtrA depends on these and ClpP, which are present throughout the cell cycle (7), the amino acids, which reside on alpha-helix 1 of the CtrA receiver accessory proteins RcdA, CpdR, and PopA, and the small mol- domain, and on cdG binding by PopA. These results reveal that ecule cyclic di-GMP (cdG), are required for the rapid degrada- each accessory factor plays an essential biochemical role in the regu- tion of CtrA in vivo (18–20). lated proteolysis of CtrA and demonstrate, to our knowledge, the RcdA is conserved in some alpha-proteobacteria, and its tran- first example of a multiprotein, cdG-dependent proteolytic adaptor. scription is regulated directly by CtrA in Caulobacter (18). RcdA exists as a dimer, with each monomer comprising a three-helix he alpha-proteobacterium Caulobacter crescentus is a pow- Terful model organism for understanding cell polarity, dif- Significance ferentiation, and cell-cycle regulation in bacteria (1). Each Caulobacter cell division is asymmetric, yielding a motile swarmer cell (SW) and a sessile stalked cell (ST). The stalked Controlled degradation of specific proteins is used by all cell immediately initiates chromosome replication and enters organisms to change cell behavior in response to internal or a new division cycle, whereas the swarmer cell must first differ- external cues. Because ATP-dependent proteases, such as ClpXP, entiate into a stalked cell before undergoing cell division (Fig. 1). have a broad range of targets, accessory proteins called adaptors An elaborate network of two-component signaling proteins are often necessary for selective substrate proteolysis. Here we orchestrates the Caulobacter cycle of division and development show that three proteins work together as a multicomponent adaptor to stimulate the degradation of a key regulatory pro- (2). The essential DNA-binding response regulator CtrA is at the Caulobacter crescentus center of this regulatory scheme, activating or repressing the tein, CtrA, in . The adaptor is only func- tional when one of the components, CpdR, is unphosphorylated transcription of >100 genes that are required for cell division, and when another component, PopA, is bound to the signaling motility, DNA methylation, and other processes (3). Because molecule cyclic diguanylate. These features ensure that CtrA is CtrA also inhibits the initiation of chromosome replication (4, only proteolyzed during a specific window in the Caulobacter 5), its activity must be temporarily eliminated at the G1–S cell- cell-division cycle. cycle transition for DNA replication and the subsequent cell division to occur. Inactivation of CtrA is achieved through two Author contributions: S.C.S., K.K.J., J.J.Z., K.T., A.K., P.C., and K.R.R. designed research; redundant mechanisms: dephosphorylation (6) and proteolysis by S.C.S., K.K.J., J.J.Z., K.T., A.K., and K.R.R. performed research; S.C.S., K.K.J., J.J.Z., A.K., P.C., theproteaseClpXP(7). and K.R.R. analyzed data; and P.C. and K.R.R. wrote the paper. ClpXP is a highly conserved ATP-dependent protease crucial The authors declare no conflict of interest. for protein quality control and in regulated degradation of key This article is a PNAS Direct Submission. substrates to implement developmental switches and adapt to 1K.K.J. and J.J.Z. contributed equally to this work. external cues (8). The barrel-shaped oligomer of ClpP contains 2To whom correspondence may be addressed. Email: [email protected] or pchien@ hydrolysis active sites on its inner surface. To access these sites, biochem.umass.edu. substrates are recognized, unfolded, and translocated into the This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. ClpP chamber by a ring-shaped hexamer of the ATPase ClpX. 1073/pnas.1407862111/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1407862111 PNAS Early Edition | 1of6 Downloaded by guest on September 28, 2021 second messengers to promote robust degradation of an es- sential cell-cycle regulator, reconciling in vitro and cellular SW ST PD ClpXP observations of CtrA degradation. CpdR Results RcdA Identification of Degradation-Enhancing Amino Acids in the CtrA Receiver Domain. CtrA contains two internal signals that de- CtrA termine its pattern of cell cycle-dependent proteolysis. One de- PopA-cdG terminant consists of two alanine residues at the C terminus, which are required for direct recognition by ClpX (17, 26, 28), Caulobacter and the other signal resides somewhere in the first 56 amino Fig. 1. CtrA dynamics during the cell cycle. SW, swarmer cell; acids of the CtrA receiver domain (25). We reasoned that amino ST, stalked cell; PD, predivisional cell. Straight lines represent pili. Wavy lines represent flagella. Filled circles denote nonreplicating chromosomes. Theta acids in CtrA that are important for degradation would be structures denote replicating chromosomes. Red and pink shading represent coconserved with rcdA and cpdR, which are found in ∼1/3 of CtrA protein. sequenced α-proteobacteria (29). We therefore aligned CtrA protein sequences from genomes in 26 different genera of the α-proteobacteria (Fig. S1; ref. 30) and identified residues in the bundle connected by disordered loops and a disordered C-ter- first half of the CtrA receiver domain that are highly conserved minal peptide necessary for regulated CtrA proteolysis (21). in genomes containing homologs of rcdA and cpdR, but that are CpdR is a single-domain response regulator that is phosphory- divergent in bacteria that lack these genes. We then mapped lated by the histidine kinase CckA and the histidine phospho- these residues onto a model of the CtrA receiver domain based transferase ChpT, which also act on CtrA (22). However, CpdR on the structure of the response regulator Spo0F (Protein Data must be unphosphorylated to promote CtrA degradation (19). Bank ID code 1NAT; ref. 31). Six of the residues we identified This signaling logic dictates that when CtrA is phosphorylated are predicted to lie on the exposed surface of the first alpha-helix and active, it will also be stabilized due to the phosphorylation of (α1) of CtrA (S10, A11, Q14, K21, S22, and E23), whereas two of CpdR. Before S phase, when both are dephosphorylated, the the residues are predicted to be partially or completely buried in activity and stability of CtrA are concomitantly reduced (6, 19). the interior of the protein (F25 and G40; Fig. 2A). PopA is composed of two tandem receiver domains and a Based on this analysis, we examined the in vivo degradation C-terminal diguanylate cyclase (DGC) domain. The DGC domain pattern of a chimeric protein containing segments of CtrA and of PopA is inactive, but cdG binding at an allosteric site is required CzcR, a nondegradable CtrA ortholog (25). CtrA–RD+15, for PopA to stimulate CtrA proteolysis in vivo (20). PopA is which contains the receiver domain and the last 15 amino acids thought to link CtrA proteolysis to cellular cdG levels, which of CtrA, but lacks the DNA-binding domain, has the same cell- transiently increase during swarmer cell differentiation (23, 24).
Recommended publications
  • Supplementary Materials: Evaluation of Cytotoxicity and Α-Glucosidase Inhibitory Activity of Amide and Polyamino-Derivatives of Lupane Triterpenoids
    Supplementary Materials: Evaluation of cytotoxicity and α-glucosidase inhibitory activity of amide and polyamino-derivatives of lupane triterpenoids Oxana B. Kazakova1*, Gul'nara V. Giniyatullina1, Akhat G. Mustafin1, Denis A. Babkov2, Elena V. Sokolova2, Alexander A. Spasov2* 1Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences, 71, pr. Oktyabrya, 450054 Ufa, Russian Federation 2Scientific Center for Innovative Drugs, Volgograd State Medical University, Novorossiyskaya st. 39, Volgograd 400087, Russian Federation Correspondence Prof. Dr. Oxana B. Kazakova Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences 71 Prospeсt Oktyabrya Ufa, 450054 Russian Federation E-mail: [email protected] Prof. Dr. Alexander A. Spasov Scientific Center for Innovative Drugs of the Volgograd State Medical University 39 Novorossiyskaya st. Volgograd, 400087 Russian Federation E-mail: [email protected] Figure S1. 1H and 13C of compound 2. H NH N H O H O H 2 2 Figure S2. 1H and 13C of compound 4. NH2 O H O H CH3 O O H H3C O H 4 3 Figure S3. Anticancer screening data of compound 2 at single dose assay 4 Figure S4. Anticancer screening data of compound 7 at single dose assay 5 Figure S5. Anticancer screening data of compound 8 at single dose assay 6 Figure S6. Anticancer screening data of compound 9 at single dose assay 7 Figure S7. Anticancer screening data of compound 12 at single dose assay 8 Figure S8. Anticancer screening data of compound 13 at single dose assay 9 Figure S9. Anticancer screening data of compound 14 at single dose assay 10 Figure S10.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Yeast Genome Gazetteer P35-65
    gazetteer Metabolism 35 tRNA modification mitochondrial transport amino-acid metabolism other tRNA-transcription activities vesicular transport (Golgi network, etc.) nitrogen and sulphur metabolism mRNA synthesis peroxisomal transport nucleotide metabolism mRNA processing (splicing) vacuolar transport phosphate metabolism mRNA processing (5’-end, 3’-end processing extracellular transport carbohydrate metabolism and mRNA degradation) cellular import lipid, fatty-acid and sterol metabolism other mRNA-transcription activities other intracellular-transport activities biosynthesis of vitamins, cofactors and RNA transport prosthetic groups other transcription activities Cellular organization and biogenesis 54 ionic homeostasis organization and biogenesis of cell wall and Protein synthesis 48 plasma membrane Energy 40 ribosomal proteins organization and biogenesis of glycolysis translation (initiation,elongation and cytoskeleton gluconeogenesis termination) organization and biogenesis of endoplasmic pentose-phosphate pathway translational control reticulum and Golgi tricarboxylic-acid pathway tRNA synthetases organization and biogenesis of chromosome respiration other protein-synthesis activities structure fermentation mitochondrial organization and biogenesis metabolism of energy reserves (glycogen Protein destination 49 peroxisomal organization and biogenesis and trehalose) protein folding and stabilization endosomal organization and biogenesis other energy-generation activities protein targeting, sorting and translocation vacuolar and lysosomal
    [Show full text]
  • Letters to Nature
    letters to nature Received 7 July; accepted 21 September 1998. 26. Tronrud, D. E. Conjugate-direction minimization: an improved method for the re®nement of macromolecules. Acta Crystallogr. A 48, 912±916 (1992). 1. Dalbey, R. E., Lively, M. O., Bron, S. & van Dijl, J. M. The chemistry and enzymology of the type 1 27. Wolfe, P. B., Wickner, W. & Goodman, J. M. Sequence of the leader peptidase gene of Escherichia coli signal peptidases. Protein Sci. 6, 1129±1138 (1997). and the orientation of leader peptidase in the bacterial envelope. J. Biol. Chem. 258, 12073±12080 2. Kuo, D. W. et al. Escherichia coli leader peptidase: production of an active form lacking a requirement (1983). for detergent and development of peptide substrates. Arch. Biochem. Biophys. 303, 274±280 (1993). 28. Kraulis, P.G. Molscript: a program to produce both detailed and schematic plots of protein structures. 3. Tschantz, W. R. et al. Characterization of a soluble, catalytically active form of Escherichia coli leader J. Appl. Crystallogr. 24, 946±950 (1991). peptidase: requirement of detergent or phospholipid for optimal activity. Biochemistry 34, 3935±3941 29. Nicholls, A., Sharp, K. A. & Honig, B. Protein folding and association: insights from the interfacial and (1995). the thermodynamic properties of hydrocarbons. Proteins Struct. Funct. Genet. 11, 281±296 (1991). 4. Allsop, A. E. et al.inAnti-Infectives, Recent Advances in Chemistry and Structure-Activity Relationships 30. Meritt, E. A. & Bacon, D. J. Raster3D: photorealistic molecular graphics. Methods Enzymol. 277, 505± (eds Bently, P. H. & O'Hanlon, P. J.) 61±72 (R. Soc. Chem., Cambridge, 1997).
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110747 A1 Ramseier Et Al
    US 200601 10747A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110747 A1 Ramseier et al. (43) Pub. Date: May 25, 2006 (54) PROCESS FOR IMPROVED PROTEIN (60) Provisional application No. 60/591489, filed on Jul. EXPRESSION BY STRAIN ENGINEERING 26, 2004. (75) Inventors: Thomas M. Ramseier, Poway, CA Publication Classification (US); Hongfan Jin, San Diego, CA (51) Int. Cl. (US); Charles H. Squires, Poway, CA CI2O I/68 (2006.01) (US) GOIN 33/53 (2006.01) CI2N 15/74 (2006.01) Correspondence Address: (52) U.S. Cl. ................................ 435/6: 435/7.1; 435/471 KING & SPALDING LLP 118O PEACHTREE STREET (57) ABSTRACT ATLANTA, GA 30309 (US) This invention is a process for improving the production levels of recombinant proteins or peptides or improving the (73) Assignee: Dow Global Technologies Inc., Midland, level of active recombinant proteins or peptides expressed in MI (US) host cells. The invention is a process of comparing two genetic profiles of a cell that expresses a recombinant (21) Appl. No.: 11/189,375 protein and modifying the cell to change the expression of a gene product that is upregulated in response to the recom (22) Filed: Jul. 26, 2005 binant protein expression. The process can improve protein production or can improve protein quality, for example, by Related U.S. Application Data increasing solubility of a recombinant protein. Patent Application Publication May 25, 2006 Sheet 1 of 15 US 2006/0110747 A1 Figure 1 09 010909070£020\,0 10°0 Patent Application Publication May 25, 2006 Sheet 2 of 15 US 2006/0110747 A1 Figure 2 Ester sers Custer || || || || || HH-I-H 1 H4 s a cisiers TT closers | | | | | | Ya S T RXFO 1961.
    [Show full text]
  • Insights Into the Role and Mechanism of the AAA+ Adaptor Clps
    Insights into the role and mechanism of the AAA+ adaptor ClpS by Jennifer Yuan Hou Sc.B. Biochemistry Brown University, 2002 SUBMITTED TO THE DEPARTMENT OF BIOLOGY IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY AT THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY JUNE 2009 © 2009 Jennifer Yuan Hou. All Rights Reserved. The author hereby grants to MIT permission to reproduce and to distribute publicly paper and electronic copies of this thesis document in whole or in part in any medium now known or hereafter created. Signature of Author:_______________________________________________________ Department of Biology May 22, 2009 Certified by:_____________________________________________________________ Tania A. Baker E. C. Whitehead Professor of Biology Thesis Supervisor Accepted by:_____________________________________________________________ Stephen P. Bell Professor of Biology Co-Chair, Graduate Committee 1 2 Insights into the role and mechanism of the AAA+ adaptor ClpS by Jennifer Yuan Hou Submitted to the Department of Biology on May 22, 2009 in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy at the Massachusetts Institute of Technology ABSTRACT Protein degradation is a vital process in cells for quality control and participation in regulatory pathways. Intracellular ATP-dependent proteases are responsible for regulated degradation and are highly controlled in their function, especially with respect to substrate selectivity. Adaptor proteins that can associate with the proteases add an additional layer of control to substrate selection. Thus, understanding the mechanism and role of adaptor proteins is a critical component to understanding how proteases choose their substrates. In this thesis, I examine the role of the intracellular protease ClpAP and its adaptor ClpS in Escherichia coli.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • Mitochondrial Clpx Activates an Essential Biosynthetic Enzyme Through Partial Unfolding Julia R Kardon1,2,3*, Jamie a Moroco4†, John R Engen4, Tania a Baker2,3*
    RESEARCH ARTICLE Mitochondrial ClpX activates an essential biosynthetic enzyme through partial unfolding Julia R Kardon1,2,3*, Jamie A Moroco4†, John R Engen4, Tania A Baker2,3* 1Department of Biochemistry, Brandeis University, Waltham, United States; 2Department of Biology, Massachusetts Institute of Technology, Cambridge, United States; 3Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, United States; 4Department of Chemistry and Chemical Biology, Northeastern University, Boston, United States Abstract Mitochondria control the activity, quality, and lifetime of their proteins with an autonomous system of chaperones, but the signals that direct substrate-chaperone interactions and outcomes are poorly understood. We previously discovered that the mitochondrial AAA+ protein unfoldase ClpX (mtClpX) activates the initiating enzyme for heme biosynthesis, 5- aminolevulinic acid synthase (ALAS), by promoting cofactor incorporation. Here, we ask how mtClpX accomplishes this activation. Using S. cerevisiae proteins, we identified sequence and structural features within ALAS that position mtClpX and provide it with a grip for acting on ALAS. Observation of ALAS undergoing remodeling by mtClpX revealed that unfolding is limited to a region extending from the mtClpX-binding site to the active site. Unfolding along this path is required for mtClpX to gate cofactor binding to ALAS. This targeted unfolding contrasts with the *For correspondence: global unfolding canonically executed by ClpX homologs and provides insight into how substrate- [email protected] (JRK); chaperone interactions direct the outcome of remodeling. [email protected] (TAB) Present address: †Broad Institute, Cambridge, United States Introduction AAA+ protein unfoldases use the energy of ATP hydrolysis to pull apart the structures of their sub- Competing interests: The strate proteins.
    [Show full text]
  • Viral Elements and Their Potential Influence on Microbial Processes Along the Permanently Stratified Cariaco Basin Redoxcline
    The ISME Journal https://doi.org/10.1038/s41396-020-00739-3 ARTICLE Viral elements and their potential influence on microbial processes along the permanently stratified Cariaco Basin redoxcline 1 2 3 4 5 Paraskevi Mara ● Dean Vik ● Maria G. Pachiadaki ● Elizabeth A. Suter ● Bonnie Poulos ● 6 2,7 1 Gordon T. Taylor ● Matthew B. Sullivan ● Virginia P. Edgcomb Received: 22 January 2020 / Revised: 18 July 2020 / Accepted: 5 August 2020 © The Author(s) 2020. This article is published with open access Abstract Little is known about viruses in oxygen-deficient water columns (ODWCs). In surface ocean waters, viruses are known to act as gene vectors among susceptible hosts. Some of these genes may have metabolic functions and are thus termed auxiliary metabolic genes (AMGs). AMGs introduced to new hosts by viruses can enhance viral replication and/or potentially affect biogeochemical cycles by modulating key microbial pathways. Here we identify 748 viral populations that cluster into 94 genera along a vertical geochemical gradient in the Cariaco Basin, a permanently stratified and euxinic ocean basin. The viral communities in this ODWC appear to be relatively novel as 80 of these viral genera contained no reference 1234567890();,: 1234567890();,: viral sequences, likely due to the isolation and unique features of this system. We identify viral elements that encode AMGs implicated in distinctive processes, such as sulfur cycling, acetate fermentation, signal transduction, [Fe–S] formation, and N-glycosylation. These AMG-encoding viruses include two putative Mu-like viruses, and viral-like regions that may constitute degraded prophages that have been modified by transposable elements.
    [Show full text]
  • Glucagon-Like Peptide-1 Receptor Agonists Increase Pancreatic Mass by Induction of Protein Synthesis
    Page 1 of 73 Diabetes Glucagon-like peptide-1 receptor agonists increase pancreatic mass by induction of protein synthesis Jacqueline A. Koehler1, Laurie L. Baggio1, Xiemin Cao1, Tahmid Abdulla1, Jonathan E. Campbell, Thomas Secher2, Jacob Jelsing2, Brett Larsen1, Daniel J. Drucker1 From the1 Department of Medicine, Tanenbaum-Lunenfeld Research Institute, Mt. Sinai Hospital and 2Gubra, Hørsholm, Denmark Running title: GLP-1 increases pancreatic protein synthesis Key Words: glucagon-like peptide 1, glucagon-like peptide-1 receptor, incretin, exocrine pancreas Word Count 4,000 Figures 4 Tables 1 Address correspondence to: Daniel J. Drucker M.D. Lunenfeld-Tanenbaum Research Institute Mt. Sinai Hospital 600 University Ave TCP5-1004 Toronto Ontario Canada M5G 1X5 416-361-2661 V 416-361-2669 F [email protected] 1 Diabetes Publish Ahead of Print, published online October 2, 2014 Diabetes Page 2 of 73 Abstract Glucagon-like peptide-1 (GLP-1) controls glucose homeostasis by regulating secretion of insulin and glucagon through a single GLP-1 receptor (GLP-1R). GLP-1R agonists also increase pancreatic weight in some preclinical studies through poorly understood mechanisms. Here we demonstrate that the increase in pancreatic weight following activation of GLP-1R signaling in mice reflects an increase in acinar cell mass, without changes in ductal compartments or β-cell mass. GLP-1R agonists did not increase pancreatic DNA content or the number of Ki67+ cells in the exocrine compartment, however pancreatic protein content was increased in mice treated with exendin-4 or liraglutide. The increased pancreatic mass and protein content was independent of cholecystokinin receptors, associated with a rapid increase in S6 kinase phosphorylation, and mediated through the GLP-1 receptor.
    [Show full text]
  • CRISPR Screens in Physiologic Medium Reveal Conditionally Essential Genes in Human Cells
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.31.275107; this version posted August 31, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. CRISPR screens in physiologic medium reveal conditionally essential genes in human cells Nicholas J. Rossiter1, Kimberly S. Huggler1,2, Charles H. Adelmann3,4,5,6, Heather R. Keys3, Ross W. Soens1,2, David M. Sabatini3,4,5,6*, and Jason R. Cantor1,2,7,8* 1Morgridge Institute for Research, Madison, WI 53715, USA 2Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA 3Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA 4Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA 5Koch Institute for Integrative Cancer Research, Cambridge, MA 02139, USA 6Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02142, USA 7Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA 8Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI 53705, USA *Correspondence: [email protected] or [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2020.08.31.275107; this version posted August 31, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. SUMMARY Forward genetic screens across hundreds of diverse cancer cell lines have started to define the genetic dependencies of proliferating human cells and how these vary by genotype and lineage. Most screens, however, have been carried out in culture media that poorly resemble metabolite availability in human blood.
    [Show full text]
  • Mitochondrial Protein Quality Control in Cancer
    International Journal of Molecular Sciences Review Failure to Guard: Mitochondrial Protein Quality Control in Cancer Joseph E. Friedlander 1,†, Ning Shen 1,2,†, Aozhuo Zeng 1, Sovannarith Korm 1 and Hui Feng 1,2,* 1 Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA; [email protected] (J.E.F.); [email protected] (N.S.); [email protected] (A.Z.); [email protected] (S.K.) 2 Department of Medicine, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA 02118, USA * Correspondence: [email protected]; Tel.: +1-617-358-4688; Fax: +1-617-358-1599 † Equal contribution. Abstract: Mitochondria are energetic and dynamic organelles with a crucial role in bioenergetics, metabolism, and signaling. Mitochondrial proteins, encoded by both nuclear and mitochondrial DNA, must be properly regulated to ensure proteostasis. Mitochondrial protein quality control (MPQC) serves as a critical surveillance system, employing different pathways and regulators as cellular guardians to ensure mitochondrial protein quality and quantity. In this review, we describe key pathways and players in MPQC, such as mitochondrial protein translocation-associated degradation, mitochondrial stress responses, chaperones, and proteases, and how they work together to safeguard mitochondrial health and integrity. Deregulated MPQC leads to proteotoxicity and dysfunctional mitochondria, which contributes to numerous human diseases, including cancer. We discuss how alterations in MPQC components are linked to tumorigenesis, whether they act as drivers, suppressors, or both. Finally, we summarize recent advances that seek to target these Citation: Friedlander, J.E.; Shen, N.; alterations for the development of anti-cancer drugs. Zeng, A.; Korm, S.; Feng, H.
    [Show full text]